Immuno-Informatics Insight into the Relationship Between Cholesterol and Cytokines in Cutaneous Leishmaniasis: From Clinics to Computation

Overview

Journal Sultan Qaboos Univ Med J

Specialty General Medicine

Date 2024 Dec 5

PMID 39634810

Authors

Evan H Sulaiman

Layth J Mohammad

Allaa H Thanoon

Isaac Karimi

Affiliations

Soon will be listed here.

Abstract

Objectives: The role of serum cholesterol and its interactions with cytokines in human cutaneous leishmaniasis (CL) pathophysiology is unknown. This study aimed to evaluate the correlation among serum total cholesterol (TC), very-low-density lipoprotein cholesterol (VLDL-C), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), triglycerides (TG) and cytokines (including interleukin [IL] 10), IL-12 and tumour necrosis factor-alpha [TNF-α]) in CL. The cholesterol-cytokine network was analysed to illuminate the pathogenesis of CL.

Methods: This case-control study was conducted from December 2022 to March 2023 in hospitals within Baghdad and Wasit provinces, Iraq, and included CL and CL-free subjects ranging between 20-30 years of age. The serum samples were analysed via commercial kits to detect TC, IL-10, IL-12, TNF-α, VLDL-C, LDL-C, HDL-C and TG levels. Computational efforts to dissect cholesterol-protein interaction networks were employed using STITCH.

Results: A total of 50 CL and 25 control subjects were included. The TC, HDL-C and LDL-C levels in CL patients were markedly lower ( = 0.0001) than in control subjects, whereas the IL-10, IL-12, TNF-α, VLDL-C and TG levels were higher in CL patients. Serum cholesterol showed no correlation with cytokines; however, a significant correlation (r = 0.57; = 0.026) was observed between IL-12 and TNF-α. Within the cholesterol-protein network, cholesterol potentially interacted with IL-10, connecting cholesterol to modules with immunological significance, including TRAF1, TRAF2 and TNF receptor superfamily member 1B, as well as IL-10, IL-10RA and IL-12RB1.

Conclusion: This study showed the alteration of lipid and lipoprotein in CL and introduced 2 immunological modules in CL, highlighting the importance of the altered cholesterol-cytokine interaction network in CL.

References

Young D . Effects of drugs on clinical laboratory tests. Ann Clin Biochem. 1997; 34 ( Pt 6):579-81. DOI: 10.1177/000456329703400601. View

Pucadyil T, Chattopadhyay A . Role of cholesterol in the function and organization of G-protein coupled receptors. Prog Lipid Res. 2006; 45(4):295-333. DOI: 10.1016/j.plipres.2006.02.002. View

de Carvalho B, Vital T, Osiro J, Gomes C, Noronha E, Dallago B . Multiparametric analysis of host and parasite elements in new world tegumentary leishmaniasis. Front Cell Infect Microbiol. 2022; 12:956112. PMC: 9395741. DOI: 10.3389/fcimb.2022.956112. View

Venkatesha S, Dudics S, Acharya B, Moudgil K . Cytokine-modulating strategies and newer cytokine targets for arthritis therapy. Int J Mol Sci. 2015; 16(1):887-906. PMC: 4307281. DOI: 10.3390/ijms16010887. View

Firouzjaie-Karder F, Akhoundi B, Mohebali M, Ardalan F, Rahimi-Foroushani A, Mesgarian F . A Comparative Evaluation of Regulatory T Cells Profile among Acute and Chronic Cutaneous Leishmaniasis Using Flow Cytometry. Iran J Parasitol. 2019; 14(2):190-196. PMC: 6737365. View

Saunders E, McConville M . Immunometabolism of Leishmania granulomas. Immunol Cell Biol. 2020; 98(10):832-844. DOI: 10.1111/imcb.12394. View

FRIEDEWALD W, Levy R, Fredrickson D . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972; 18(6):499-502. View

Maspi N, Abdoli A, Ghaffarifar F . Pro- and anti-inflammatory cytokines in cutaneous leishmaniasis: a review. Pathog Glob Health. 2016; 110(6):247-260. PMC: 5070640. DOI: 10.1080/20477724.2016.1232042. View

Aronson N, Herwaldt B, Libman M, Pearson R, Lopez-Velez R, Weina P . Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Clin Infect Dis. 2016; 63(12):e202-e264. DOI: 10.1093/cid/ciw670. View

10.

Varela M, Bezerra M, Santana F, Gomes M, de Jesus Almeida P, da Cruz G . Association between Hypertriglyceridemia and Disease Severity in Visceral Leishmaniasis. Am J Trop Med Hyg. 2021; 106(2):643-647. PMC: 8832909. DOI: 10.4269/ajtmh.21-0260. View

11.

Pucadyil T, Chattopadhyay A . Cholesterol: a potential therapeutic target in Leishmania infection?. Trends Parasitol. 2006; 23(2):49-53. DOI: 10.1016/j.pt.2006.12.003. View

12.

Kumar G, Roy S, Jafurulla M, Mandal C, Chattopadhyay A . Statin-induced chronic cholesterol depletion inhibits Leishmania donovani infection: Relevance of optimum host membrane cholesterol. Biochim Biophys Acta. 2016; 1858(9):2088-2096. DOI: 10.1016/j.bbamem.2016.06.010. View

13.

Guegan H, Ory K, Belaz S, Jan A, Dion S, Legentil L . In vitro and in vivo immunomodulatory properties of octyl-β-D-galactofuranoside during Leishmania donovani infection. Parasit Vectors. 2019; 12(1):600. PMC: 6929453. DOI: 10.1186/s13071-019-3858-0. View

14.

Escribano D, Tvarijonaviciute A, Kocaturk M, Ceron J, Pardo-Marin L, Torrecillas A . Serum apolipoprotein-A1 as a possible biomarker for monitoring treatment of canine leishmaniosis. Comp Immunol Microbiol Infect Dis. 2016; 49:82-87. DOI: 10.1016/j.cimid.2016.10.002. View

15.

Kuschnir R, Pereira L, Dutra M, de Paula L, Silva-Freitas M, Correa-Castro G . High levels of anti-Leishmania IgG3 and low CD4 T cells count were associated with relapses in visceral leishmaniasis. BMC Infect Dis. 2021; 21(1):369. PMC: 8056614. DOI: 10.1186/s12879-021-06051-5. View

16.

Colomba C, Di Carlo P, Scarlata F, Iaria C, Barberi G, Fama F . Visceral leishmaniasis, hypertriglyceridemia and secondary hemophagocytic lymphohistiocytosis. Infection. 2016; 44(3):391-2. DOI: 10.1007/s15010-016-0881-3. View

17.

Deslyper G, Doherty D, Carolan J, Holland C . The role of the liver in the migration of parasites of global significance. Parasit Vectors. 2019; 12(1):531. PMC: 6842148. DOI: 10.1186/s13071-019-3791-2. View

18.

Bharati K . Human genetic polymorphism and Leishmaniasis. Infect Genet Evol. 2022; 98:105203. DOI: 10.1016/j.meegid.2021.105203. View

19.

Crane J, Tamm L . Role of cholesterol in the formation and nature of lipid rafts in planar and spherical model membranes. Biophys J. 2004; 86(5):2965-79. PMC: 1304164. DOI: 10.1016/S0006-3495(04)74347-7. View

20.

Oliveira W, Ribeiro L, Schrieffer A, Machado P, Carvalho E, Bacellar O . The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of human tegumentary leishmaniasis. Cytokine. 2014; 66(2):127-32. PMC: 4047562. DOI: 10.1016/j.cyto.2013.12.016. View